AUROPHARMA Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > auropharma

Technical Analysis

Technical Strength: 8.5 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 69.5. According to RSI analysis, auropharma is technically strong. 9.0 AUROPHARMA RSI Chart
MACD (?) MACD: 26.8 and Signal Line: 19.5. According to MACD analysis, auropharma is technically strong. 8.0 AUROPHARMA MACD Chart
Simple Moving Average (?) According to simple moving average analysis, auropharma is in a strong uptrend. Major support levels are 834.8825, 800.29, 575.182. 10.0 AUROPHARMA Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, auropharma is in a strong uptrend. Major support levels are 840.2191, 789.886, 651.1832. 10.0 AUROPHARMA Exponential Moving Average Chart
Bollinger Bands (?) %b is 1.02. According to bollinger bands, auropharma has hit the upper band which is a positive signal. 9.0 AUROPHARMA Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 864.7068 and 846.7. Resistance level is 923.0. 6.5 AUROPHARMA Fibonacci Retracement Chart
Average True Range (?) ATR: 29.6 NA AUROPHARMA Average True Range Chart
Average Directional Index (?) ADX is 31 which means AUROPHARMA is in a trend. NA AUROPHARMA Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
August 07, 2020
Open Price 914.0
High Price 923.0
Low Price 898.0
Close Price 906.45
Absolute Change -3.3
Percentage Change -0.363%
Weekly Change 3.64%
Monthly Change 10.4%
Yearly Change 64.2%
52-week high 923.0
52-week low 288.85
Corporate Actions
ExDate Purpose
August 21, 2020 ANNUAL GENERAL MEETING
February 17, 2020 INT DIV-RS 1.75 PER SH
November 21, 2019 INT DIV-RS 1.25 PER SH
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)1.08
Confidence in Beta3%
Market Capital Rs. 52937.0 Cr
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 07 August 2020: Deliverable Quantity:1.53e+06 NA AUROPHARMA Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 07 August 2020: Daily Volatility:0.6992 NA AUROPHARMA Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 07 August 2020: PCR_OI:0.526 PCR:0.441 NA AUROPHARMA PCR Chart
Option Pain (?) 07 August 2020: Max Pain:840.0 NA AUROPHARMA Option Pain Chart
Premium (?) 07 August 2020 Premium: 2.5 Futures OI:14413100.0 NA AUROPHARMA Premium Chart
Option_MAX_OI (?) 07 August 2020: Price:906.45 Put with maximum OI:800.0 Call with maximum OI:1000.0 NA AUROPHARMA Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
August 27, 2020 908.95 14413100.0 9598.0 9598.0 906.45
September 24, 2020 910.75 135200.0 97.0 97.0 906.45
October 29, 2020 910.2 9100.0 1.0 1.0 906.45

Announcements

August 03, 2020 Book Closure Aurobindo Pharma Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 25-Aug-2020 to 27-Aug-2020 for the purpose of Meeting.
June 27, 2019 Related Party Transactions Aurobindo Pharma Limited has informed the Exchange regarding Disclosure of Related Party Transactions under Reg 23(9) of SEBI (LODR), 2015 for the half year ended March 31, 2019.
See all Announcements

Board Meetings

Date Meeting Date Purpose
August 05, 2020 August 12, 2020 Financial Results/Dividend To consider and approve the financial results for the period ended Jun 30, 2020 and dividend
May 27, 2020 June 03, 2020 Financial Results To consider and approve the financial results for the period ended March 31, 2020
See all Board Meetings

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play